Edwards Lifesciences (EW) Short term Debt (2009 - 2018)
Edwards Lifesciences (EW) posted Short term Debt of $599.9 million for Q3 2018, little changed on a QoQ basis from $599.2 million in Q2 2018, and up 1345.54% year-over-year from $41.5 million in Q3 2017.
Powered by 
Analysis
Edwards Lifesciences (EW) Short term Debt (2009 - 2018) Analysis & Trends
Edwards Lifesciences has reported Short term Debt for 6 years, with the latest figure at $599.9 million in Q3 2018.
- On a quarterly basis, Short term Debt rose 1345.54% year-over-year to $599.9 million in Q3 2018; TTM through Sep 2018 was $599.9 million, a 1345.54% increase from a year earlier, with the FY2017 full-year figure at $598.0 million, changed N/A from the prior year.
- Short term Debt was $599.9 million for Q3 2018 at Edwards Lifesciences, roughly flat from $599.2 million in the prior quarter.
- The five-year high for Short term Debt was $599.9 million in Q3 2018, with the low at $41.5 million in Q3 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 18.70 Bn | 18.30 Bn | 1.54 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2018 | 599.90 Mn |
| Jun 30, 2018 | 599.20 Mn |
| Mar 31, 2018 | 598.60 Mn |
| Dec 31, 2017 | 598.00 Mn |
| Sep 30, 2017 | 41.50 Mn |
| Dec 31, 2012 | 189.30 Mn |
| Dec 31, 2011 | 150.40 Mn |
| Mar 31, 2011 | 149.50 Mn |
| Dec 31, 2010 | 41.80 Mn |
| Sep 30, 2010 | 100.60 Mn |
| Dec 31, 2009 | 43.90 Mn |